Alibaba Health Information Technology's (HKG:241) Solid Earnings Have Been Accounted For Conservatively
Dec 19
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Drug Retail Industry Analysis
UpdatedDec 21, 2024
DataAggregated Company Financials
Companies5
- 7D-5.7%
- 3M6.3%
- 1Y-24.6%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 5.0%, driven by a pullback from JD Health International of 8.2%. Meanwhile, Fangzhou actually outperformed within the industry, gaining 42% in the last week. However, the industry is down 25% over the past year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Hong Kong Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 21 Dec 2024 | HK$157.1b | HK$103.5b | HK$3.6b | 37.5x | 43.9x | 1.5x |
| Mon, 18 Nov 2024 | HK$170.6b | HK$104.6b | HK$3.6b | 39.1x | 47.1x | 1.6x |
| Wed, 16 Oct 2024 | HK$171.7b | HK$104.6b | HK$3.3b | 48.9x | 51.7x | 1.6x |
| Fri, 13 Sep 2024 | HK$135.1b | HK$105.0b | HK$3.3b | 36.4x | 40.6x | 1.3x |
| Sun, 11 Aug 2024 | HK$140.3b | HK$103.2b | HK$2.4b | 42x | 58x | 1.4x |
| Tue, 09 Jul 2024 | HK$134.4b | HK$101.9b | HK$2.4b | 40.8x | 56.3x | 1.3x |
| Thu, 06 Jun 2024 | HK$160.7b | HK$102.2b | HK$2.4b | 48.3x | 67.1x | 1.6x |
| Sat, 04 May 2024 | HK$170.4b | HK$103.6b | HK$2.3b | 50.9x | 73.2x | 1.6x |
| Mon, 01 Apr 2024 | HK$158.8b | HK$104.0b | HK$2.3b | 47.9x | 68x | 1.5x |
| Wed, 28 Feb 2024 | HK$177.1b | HK$105.1b | -HK$1,455,765,369.84 | 58.7x | -121.7x | 1.7x |
| Fri, 26 Jan 2024 | HK$167.9b | HK$105.4b | -HK$1,460,184,933.00 | 54.2x | -115x | 1.6x |
| Sun, 24 Dec 2023 | HK$197.9b | HK$105.9b | -HK$1,466,795,228.00 | 61.3x | -134.9x | 1.9x |
| Tue, 21 Nov 2023 | HK$220.2b | HK$103.5b | -HK$1,763,689,326.00 | 88.8x | -124.9x | 2.1x |
| Thu, 19 Oct 2023 | HK$209.0b | HK$101.8b | -HK$1,736,368,294.00 | 87.3x | -120.3x | 2.1x |
| Sat, 16 Sep 2023 | HK$228.1b | HK$102.8b | -HK$1,682,295,105.00 | 84.3x | -135.6x | 2.2x |
| Mon, 14 Aug 2023 | HK$269.5b | HK$95.6b | -HK$4,146,464,127.00 | 124.6x | -65x | 2.8x |
| Wed, 12 Jul 2023 | HK$262.9b | HK$96.2b | -HK$4,172,066,148.00 | 112.9x | -63x | 2.7x |
| Fri, 09 Jun 2023 | HK$270.6b | HK$96.9b | -HK$4,285,130,679.00 | 248.8x | -63.2x | 2.8x |
| Sun, 07 May 2023 | HK$306.1b | HK$95.5b | -HK$4,888,311,446.00 | 463x | -62.6x | 3.2x |
| Tue, 04 Apr 2023 | HK$315.7b | HK$95.8b | -HK$4,906,227,812.00 | 481.3x | -64.3x | 3.3x |
Price to Earnings Ratio
-192.3x
Current Industry PE
- Investors are pessimistic on the Hong Kong Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 44.4x which is lower than its 3-year average PE of 113x.
- The 3-year average PS ratio of 2.0x is higher than the industry's current PS ratio of 1.5x.
Past Earnings Growth
- Total earnings for the Drug Retail industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 8.9% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Hong Kong Drug Retail compare with similar industries?
| HK Market | -0.53% | |
| Consumer Staples | -3.39% | |
| Food and Staples Retail | -4.36% | |
| Drug Retail | -5.72% | |
| Food Retail | 2.24% | |
| Food Distributors | 0.54% | |
| Big Box Super Stores | -4.69% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 6086 Fangzhou | HK$7.34 | 36.2% +HK$2.6b | n/a | PS3.7x | |
| 314 Sipai Health Technology | HK$5.44 | 5.8% +HK$229.0m | -20.0% | PS0.8x |